Xiaoling Wang
Capital Medical University
8 Papers
6 Citations
Xiaoling Wang is an academic researcher from Capital Medical University. The author has contributed to research in topics: Guideline & Medicine. The author has an hindex of 2, co-authored 7 publications.
Chat about Author
Papers
Drug Clearance in Neonates: A Combination of Population Pharmacokinetic Modelling and Machine Learning Approaches to Improve Individual Prediction.
Bo Hao Tang,Zheng Guan,Karel Allegaert,Yue-E Wu,Efthymios Manolis,Stéphanie Leroux,Bu-Fan Yao,Hai-Yan Shi,Xiao Li,Xin Huang,Wen-Qi Wang,A.-Dong Shen,Xiaoling Wang,Tian-You Wang,Chen Kou,Hai-Yan Xu,Yue Zhou,Yi Zheng,Guo-Xiang Hao,Bao-Ping Xu,Alison H. Thomson,Edmund V. Capparelli,Valérie Biran,Nicolas Simon,Bernd Meibohm,Lo Yl,Lo Yl,Remedios Marques,José Esteban Peris,Irja Lutsar,Jumpei Saito,Jacobus Burggraaf,Evelyne Jacqz-Aigrain,John N. van den Anker,John N. van den Anker,Wei Zhao +35 more
TL;DR: In this paper, the authors evaluated whether combining population pharmacokinetic and machine learning approaches could provide a more accurate prediction of the clearance of renally eliminated drugs in individual neonates.
32
Medication Therapy of High-Dose Methotrexate: An Evidence-Based Practice Guideline of the Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society.
Zaiwei Song,Yang Hu,Shuang Liu,Guanru Wang,Suodi Zhai,Xianglin Zhang,Youping Li,Guanhua Du,Yuankai Shi,Yaolong Chen,Mei Dong,Rui-chen Guo,Wei Guo,Hongbing Huang,Xiao-Jun Huang,Hongmei Jing,Xiaoyan Ke,Guohui Li,Liyan Miao,Xiaohui Niu,Feng Qiu,Jingnan Shen,Jingyan Tang,Tian-You Wang,Xiaoling Wang,Zhuo Wang,Jiuhong Wu,Siyan Zhan,Bikui Zhang,Lingli Zhang,Yanhua Zhang,Wei Zhang,Limei Zhao,Li-bo Zhao,Jiancun Zhen,Huyong Zheng,Zhu Zhu,Dan Jiang,Zhencheng Huang,Zhiyuan Tan,Qiaonan Lin,Rongsheng Zhao +41 more
TL;DR: This guideline provides comprehensive and practical recommendations involving the whole process of HDMTX medication to health care providers and presents 28 recommendations, regarding evaluation prior to medication, pre-treatment and routine dosing regimen, therapeutic drug monitoring, and management of toxicities.
23
Guideline for the management of pediatric off-label use of drugs in China (2021)
Min Meng,Enmei Liu,Bo Zhang,Quan Lu,Xiaobo Zhang,Bin Ge,Ye Wu,Li Wang,Mo Wang,Zhengxiu Luo,Ziyu Hua,Xiaoling Wang,Wei Zhao,Yi Zheng,Xinan Wu,Ruiling Zhao,Wenbo Meng,L. Xiang,Gang Wang,Yun-Can Jia,Yongchuan Chen,Xiaoyan Dong,Lina Hao,Chengjun Liu,Meng Lv,Xufei Luo,Yunlan Liu,Quan Shen,W. Lei,Ping-gui Wang,Yajia Sun,Juanjuan Zhang,Ling Wang,Ruobing Lei,T. Hou,Bo Yang,Qiu Li,Yaolong Chen +37 more
TL;DR: Wang et al. as discussed by the authors developed the first guideline for the management of pediatric off-label use of drugs in China, which is to offer guidance for pediatricians, pharmacists, medical managers, policymakers, and primary care physicians.
Recommendations on off-label use of intravenous azithromycin in children
Pengxiang Zhou,Xiaoling Wang,Xianglin Zhang,Baoping Xu,Xiaomei Tong,Wei Zhou,Kunling Shen,Suodi Zhai +7 more
TL;DR: In this article, a rapid advice guideline was developed to give recommendations of rational use of intravenous azithromycin (AZM) in children, based on expert clinical experience, patients' values and preferences, and evidence availability.
10
Body Surface Area-Based Dosing Regimen of Caspofungin in Children: a Population Pharmacokinetics Confirmatory Study.
Xin-Mei Yang,Stéphanie Leroux,Thomas Storme,Daolun Zhang,Tiphaine Adam de Beaumais,Hai-Yan Shi,Yi-Lei Yang,Xiaoling Wang,Wei Zhao,Evelyne Jacqz-Aigrain +9 more
TL;DR: The population pharmacokinetic confirmed that adjustment of caspofungin dosage based on body surface area is most appropriate for pediatric use.
9